SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

BNBs price rebound and choppy consolidation are driving technical trading discussion, with traders watching support and resistance levels. Bulls see room for further upside, while bears call the bounce fragile and point to broader crypto-market and rate concerns.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Montreal, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

Sharp, volatile swings in gold miners are driving discussion, with traders linking recent weakness to rising Treasury yields, a stronger dollar, oil costs, and Fed-rate concerns; the ETNs 3x leverage magnifies the moves. The community is split between expecting further downside and treating pullbacks as buying opportunities based on a longer-term bullish view of gold.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Positive Phase 3 data for Amgens IMDELLTRA combined with AstraZenecas IMFINZI in small-cell lung cancer is drawing attention, alongside other oncology pipeline developments. Traders view the cancer portfolio as a growth driver, while some remain cautious amid AstraZenecas mixed trial record and recent share-price weakness.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak quarterly results, reduced outlook, and dividend suspension have intensified concern over recession-level appliance demand, debt, and liquidity; management attributed the demand slump partly to the Iran war. Traders are divided between fears of further financial distress and contrarian bets on an oversold rebound, with many blaming management and disputing the companys explanation.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Uniteds quarterly results and weaker profit outlook are driving attention, as rising jet-fuel costs pressured earnings despite record revenue and resilient travel demand. Traders are split between viewing the selloff as a fuel-driven risk to margins and seeing the revenue strength as support for a recovery.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is drawing attention as a leading real-world-asset tokenization project, with traders pointing to institutional adoption and expanding tokenized products. Optimism about that growth is tempered by debate over whether ONDO holders will benefit: many cite its governance-focused role and the lack of a fee-sharing mechanism, while others watch for a fee-switch proposal and note the tokens sensitivity to broader crypto moves.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Aetnas weaker 2027 Medicare Advantage star ratings are weighing on CVS sentiment, with traders citing fewer members in highly rated plans and potential pressure on quality-bonus revenue. The discussion contrasts CVSs setback with Humanas improved ratings and questions how much of the impact is already reflected in the shares.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Reports that Papa Johns largest U.S. franchisee joined Irth Capitals effort to take the company private have fueled buyout speculation. Traders are split between expecting a deal and doubting it will close, citing the boards past resistance to offers and the companys weak operating performance.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss NEST Phase 2 results for neoadjuvant BOT+BAL in colorectal cancer are drawing attention, with reports of substantial tumor responses, ctDNA clearance, and no observed recurrences during follow-up. Bullish traders view the findings as evidence of promise, while skeptics emphasize the small, nonrandomized study and ongoing concerns about execution and dilution.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is being discussed as a proxy for the broad U.S. market, with traders divided on its outlook: bearish voices cite inflation, rising rates, oil and AI-sector valuation risks, while others favor dip-buying, technical support setups and long-term index investing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026

Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026 Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026PR NewswireMORRISTOWN, N.J., Oct. 1, 2026MUC16...

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026 Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC...

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors PR Newswire MORRISTOWN, N.J., Sept. 10, 2026 Former Incyte Executive Brings Extensive Oncology, Corporate Strategy, Business Development and Medical...

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences Whitehawk Therapeutics to Participate in Upcoming Investor Conferences PR Newswire MORRISTOWN, N.J., Sept. 2, 2026 MORRISTOWN, N.J., Sept. 2, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc.(Nasdaq: WHWK), a clinical-stage...

What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now?

Does Whitehawk Therapeutics, Inc. (WHWK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wall Street Analysts Predict a 47.64% Upside in Whitehawk Therapeutics, Inc. (WHWK): Here's  What You Should Know

The mean of analysts' price targets for Whitehawk Therapeutics, Inc. (WHWK) points to a 47.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights PR Newswire MORRISTOWN, N.J., Aug. 6, 2026 Phase 1 trials for HWK-007 and HWK-016 continue to enroll; the Phase 1...

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

Biocytogen (SSE: 688796; HKEX: 02315) and Whitehawk Therapeutics, Inc. (Whitehawk, Nasdaq: WHWK) today announced a global collaboration to develop bispecific antibody-drug conjugates (BsADC). Biocytogen will provide access to up to five bispecific antibodies using its proprietary RenLite platform...

Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC...

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference PR Newswire MORRISTOWN, N.J., May 28, 2026 MORRISTOWN, N.J., May 28, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc.(Nasdaq...

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

Whitehawk Therapeutics Inc.

WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise  

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>The company expects to file applications to begin human testing for several of the new programs within the next 12 to 24 months.</li><li>Earlier this month, the company announced an $87.5 million private placement equity financing.</li><li>According to data from Koyfin, three of the six analysts covering WHWK rate it 'Buy' or higher, while the other three rate it ‘Hold.’</li></ul>Shares of Whitehawk Therapeutics Inc. (WHWK) edged 2% higher in after-hours trading on Thursday after the clinical-stage oncology company announced a new option agreement that expands its pipeline of next-generation cancer treatments.Whitehawk said it has secured rights from the firm Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs. Antibody-drug conjugates, or ADCs, are precision therapies that combine an antibody — which homes in on cancer cells — with a potent toxin to attack tumors while minimizing damage to healthy tissue.Under the deal, Whitehawk will pick its own targets, supply the antibodies, and retain full global rights and control over the new programs. The company expects to file applications to begin human testing for several of them within the next 12 to 24 months.Whitehawk currently has two candidates — HWK-007 and HWK-016 — enrolling patients in early-stage clinical trials for certain lung, ovarian, and endometrial cancers. A third program, HWK-206, is on track for regulatory clearance to start testing around mid-year.Whitehawk’s pipeline expansion is backed by fresh capital. Earlier this month, the company announced an $87.5 million private placement equity financing. Proceeds, together with existing cash, are expected to extend Whitehawk’s runway into the second half of 2028 and will be used to advance its ADC pipeline, the company then said.<h2 class="st-heading-2">WHWK’s Retail Sentiment</h2>On Stocktwits, retail sentiment around WHWK stock fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours, while message volume improved from extremely high to low levels.According to data from Koyfin, three of the six analysts covering WHWK rate it Buy or higher, while the other three rate it ‘Hold.’ The 12-month average price target on the stock is $6.5, representing a potential upside of over 51%.<a href="https://stocktwits.com/symbol/WHWK">WHWK stock</a> has gained 123% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/aktx-stock-goes-parabolic-after-hours-on-capital-raise-cancer-data-win/cZgbrxiRe8F">AKTX Stock Goes Parabolic After Hours On $5.5M Capital Raise, Cancer Data Win: Wall Street Sees 400% Upside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Whitehawk said it has secured rights from Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs.

Vanguard Extended Market ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$3.21
Prev Close	$3.25
Open	$3.23
Dividend Yield	0.00%
50-Day Moving Average	$4.00
Beta	1.20
Avg. Volume	342,575.39
PE Ratio	-2.88

52-Week High	$5.50
52-Week Low	$1.97
Market Capitalization	$183M
EPS (Annual)	-$0.3328
Price to Book	1.00
Revenue Per Employee	$310,652.17

Feed

News

Sentiment

Earnings

Fundamentals

Info

WHWK Fundamentals